Semmelweis University
Also known as: BUDA Children's Hospital, Budapest | Heart and vascular Centre, Semmelweiss University | Miskolci Semmelweis Korhaz es Egyetemi Oktatokorhaz | Semmelweis Egyetem, Hungary | Semmelweis University | Semmelweis University, 1st Department of Paediatrics | Semmelweis University, 1st Department of Pediatrics | Semmelweis University, Budapest, Hungary | Semmelweis University Department of Cardiovascular Surgery | Semmelweis University Department of Community Dentistry | Semmelweis University, Department of Conservative Dentistry | Semmelweis University, Department of Surgery, Transplantation and Gastroenterology | Semmelweis University - Dept. of Medicine and Oncology | Semmelweis University, Dept. of Ophthalmology | Semmelweis University, Head of Department of Traumatology | Semmelweis University Heart and Vascular Center | Semmelweis University II. Clinic of Obstetrics and Gynecology
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2003Last known activity
Feb 1, 2025
Timeline
1760s
- Jan 1, 1769
Semmelweis University— Founded
Drugs by trial phase (42 distinct, 38 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (18 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Other trials (10 own, 0 via acquisition)
Indications
Studied for
- Angioedema
- Angioedemas, Hereditary
- Ascorbic Acid Deficiency
- Asphyxia
- Brain Diseases
- Brain Ischemia
- Bronchopulmonary Dysplasia
- Cardiovascular Diseases
- Central Serous Chorioretinopathy
- Diabetic Retinopathy
- Glaucoma
- Glaucoma, Open-Angle
- Heart Failure
- Hematologic Diseases
- Hypertension
- Hypotension
- Hypothermia
- Hypoxia-Ischemia, Brain
- Infarction
- Influenza, Human
- Ischemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Myocardial Infarction
- Neoplasm Metastasis
- Ocular Hypertension
- Peripheral Arterial Disease
- Retinal Diseases
- Scurvy
- Shock
- Stroke
- Thrombosis
- Vitamin D Deficiency
Recent trials (50)
- NCT06746532Lead sponsorEarly Phase 1Feb 1, 2025
- NCT06747260Lead sponsorEarly Phase 1Nov 22, 2024
- NCT06603363Lead sponsorN/AOct 31, 2024
- NCT06603363Sponsor investigatorN/AOct 31, 2024
- NCT06401083Sponsor investigatorPhase 4Dec 21, 2023
- NCT06401083Lead sponsorPhase 4Dec 21, 2023
- NCT05889390Reponsible party - principal investigatorPhase 2/Phase 3Feb 20, 2023
- NCT05889390Lead sponsorPhase 2/Phase 3Feb 20, 2023
- NCT05889390Overall official - principal investigatorPhase 2/Phase 3Feb 20, 2023
- NCT06667882Sponsor investigatorN/ADec 17, 2021
- NCT06667882Lead sponsorN/ADec 17, 2021
- NCT05836610Study directorPhase 4Sep 21, 2021
- NCT05836610Reponsible party - principal investigatorPhase 4Sep 21, 2021
- NCT05836610Lead sponsorPhase 4Sep 21, 2021
- NCT05836610Overall official - principal investigatorPhase 4Sep 21, 2021
Details
- Founded
- Budapest, HU Jan 1, 1769
- Last known activity
- Feb 1, 2025